Quantitative assessment of perirenal fat density in renal cell carcinoma: a combined radiologist-driven and YOLO-based CT study
- 1Department of Radiology, School of Medicine, Tekirdağ Namık Kemal University, Tekirdağ, Türkiye
- 2Department of Software Engineering, Faculty of Engineering and Natural Sciences, Bandırma Onyedi Eylül University, Bandırma, Türkiye
Abstract
Aim: To compare perirenal adipose tissue density (PRFD) between patients with renal cell carcinoma (RCC) and healthy controls using non-enhanced computed tomography, and to compare manual measurements and YOLOv8-based machine learning (ML) of PRFD.
Materials and methods: The study involved 57 patients with confirmed RCC and 82 control subjects. PRFD was measured manually at different levels of the kidneys and other tumor features. The ML analysis utilized specific attenuation intervals to evaluate PRFD and assess agreement with manual measurements.
Results: RCC group had significantly lower PRFD values at the upper renal pole compared to controls (right: p = 0.040; left: p = 0.032), while other kidney sections showed no significant differences. In healthy controls, there was a significant right-left difference at all levels, whereas in RCC patients this was seen only at the upper pole (p = 0.005). Tumor size was positively correlated with PRFD in specific regions. Tumor volume categories were significantly associated with the presence of tumoral necrosis (p = 0.003). The ML method generally aligned with manual measurements, but accuracy varied based on the normalization technique used.
Conclusion: The study found that PRFD varies between RCC patients and controls, particularly at the upper pole, relating more closely to tumor size than to sex or histological type. As the groups were not age-matched, this difference may partly reflect age rather than disease status. The findings suggest that PRFD could be an important imaging marker for RCC evaluation.
Related
- A quantitative treatment assessment for optimizing combined virotherapy-chemotherapy regimens against HPV-induced cervical cancer
- Relative CT Number as a Quantitative Imaging Biomarker for Differentiating Sinonasal Polyp, Inverted Papilloma, and Squamous Cell Carcinoma: A Preliminary Retrospective Study
- Toripalimab combined with chemotherapy in the treatment of primary tracheal squamous cell carcinoma: a phase II proof-of-concept study
- Long-term survival with immune checkpoint inhibitors combined with bevacizumab in advanced clear cell renal cell carcinoma : A case report
- Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records
BibTeX
@article{sasani2026quantitative,
title = {{Quantitative assessment of perirenal fat density in renal cell carcinoma: a combined radiologist-driven and YOLO-based CT study}},
author = {Hadi Sasani and Mazhar Özkan and Mehmet Ali Şimşek and Hacı Murat Akgül and Ayşegül İsal Arslan},
journal = {Frontiers in Radiology},
year = {2026},
month = oct,
doi = {10.3389/fradi.2026.1911034},
url = {https://doi.org/10.3389/fradi.2026.1911034},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Quantitative assessment of perirenal fat density in renal cell carcinoma: a combined radiologist-driven and YOLO-based CT study
AU - Hadi Sasani
AU - Mazhar Özkan
AU - Mehmet Ali Şimşek
AU - Hacı Murat Akgül
AU - Ayşegül İsal Arslan
PY - 2026
DA - 2026/10/22
JO - Frontiers in Radiology
DO - 10.3389/fradi.2026.1911034
UR - https://doi.org/10.3389/fradi.2026.1911034
AB - Aim: To compare perirenal adipose tissue density (PRFD) between patients with renal cell carcinoma (RCC) and healthy controls using non-enhanced computed tomography, and to compare manual measurements and YOLOv8-based machine learning (ML) of PRFD. Materials and methods: The study involved 57 patients with confirmed RCC and 82 control subjects. PRFD was measured manually at different levels of the kidneys and other tumor features. The ML analysis utilized specific attenuation intervals to evaluate PRFD and assess agreement with manual measurements. Results: RCC group had significantly lower PRFD values at the upper renal pole compared to controls (right: p = 0.040; left: p = 0.032), while other kidney sections showed no significant differences. In healthy controls, there was a significant right-left difference at all levels, whereas in RCC patients this was seen only at the upper pole (p = 0.005). Tumor size was positively correlated with PRFD in specific regions. Tumor volume categories were significantly associated with the presence of tumoral necrosis (p = 0.003). The ML method generally aligned with manual measurements, but accuracy varied based on the normalization technique used. Conclusion: The study found that PRFD varies between RCC patients and controls, particularly at the upper pole, relating more closely to tumor size than to sex or histological type. As the groups were not age-matched, this difference may partly reflect age rather than disease status. The findings suggest that PRFD could be an important imaging marker for RCC evaluation.
SN - 2673-8740
ER -